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Abstract
Background
Reduced SHOX gene expression has been demonstrated to be associated with all 
skeletal abnormalities in Turner syndrome, other than scoliosis (and kyphosis). There 
is evidence to suggest that Turner syndrome scoliosis is clinically and radiologically 
similar to idiopathic scoliosis, although the phenotypes are dissimilar.
Study Design and Aims
This pilot gene expression study used relative quantitative real-time PCR (qRT-PCR) 
of the SHOX (Short Stature on X) gene to determine whether it is expressed in 
vertebral body growth plates in idiopathic and congenital scoliosis.  
Methods
After vertebral growth plate dissection, tissue was examined histologically and RNA 
was extracted and its integrity was assessed using a Bio-Spec Mini™, NanoDrop®
ND-1000 spectrophotometer and standard denaturing gel electrophoresis. Following 
cDNA synthesis, gene-specific optimization in a Corbett RotorGene 6000 real-time 
cycler was followed by qRT-PCR of vertebral tissue.
Results
Histological examination of vertebral samples confirmed that only growth plate was 
analysed for gene expression. Cycling and melt curves were resolved in triplicate for 
Page 1 of 22
John Wiley & Sons, Inc.
Journal of Orthopaedic Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
all samples. SHOX abundance was demonstrated in congenital and idiopathic 
scoliosis vertebral body growth plates. SHOX expression was 11-fold greater in 
idiopathic compared to congenital (N=3) scoliosis (p=0.027).
Discussion and Significance
This study confirmed that SHOX was expressed in vertebral body growth plates, 
which implies that its expression may also be associated with the scoliosis (and 
kyphosis) of Turner syndrome.  SHOX expression is reduced in Turner syndrome 
(short stature). In this study, increased SHOX expression was demonstrated in 
idiopathic scoliosis (tall stature) and congenital scoliosis.
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Background 
SHOX Gene, Turner Syndrome Phenotype and Scoliosis
The SHOX (short stature on X) homeobox gene was discovered in 1997.1  Homeobox 
genes are known to regulate development. SHOX is located on the pseudo-autosomal 
region (PAR) of the short arms of the X and Y chromosomes. During meiosis, a high 
frequency of recombination of the short arms of both the X and Y chromosomes 
occurs, predisposing to terminal deletions, mutations and duplications.2,3,4,5
Haploinsufficiency, (less than normal complement, eg. due to absence of one X 
chromosome) of the SHOX gene results in reduced expression and mesomelic short 
stature. Syndromes associated with SHOX gene abnormalities/deletions/mutations 
include idiopathic short stature, Leri-Weill, Langer and Turner syndrome (TS). 
Characteristic dysmorphic skeletal features of Turner, Leri-Weill and Langer 
syndromes include micrognathia (60%), cubitus valgus (47%), high-arched palate 
(38%), short fourth metacarpal (37%), webbed neck (25%) and Madelung deformity 
(7%).6,7,8  Scoliosis typical of the idiopathic-type (up to 28%) and kyphosis (20%) are 
also evident in Turner syndrome.9-12  SHOX gene haploinsufficiency has been linked 
to all the skeletal features of Turner syndrome except the scoliosis (and kyphosis). 
SHOX gene overdosage (greater than the normal complement), with increased 
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expression, is associated with tall stature in Turner Syndrome (gonadal 
dysgenesis).13,14
SHOX Gene Influence on Phenotype
The observed stature changes and dysmorphic skeletal features in Turner syndrome 
imply that the SHOX gene influences the timing of growth plate fusion and skeletal 
maturation.15  SHOX gene is expressed in the middle aspect (mesomelic region) of the 
upper limbs and the pharyngeal arch and has undetectable expression in embryonic 
somites which eventually form vertebrae.6  Because reduced expression of SHOX is 
associated with skeletal growth plate dysmorphism in Turner syndrome, there is 
reason to postulate that the same gene abnormality is associated with Turner 
syndrome scoliosis (and kyphosis). To date, no data regarding SHOX gene expression 
in vertebral growth plates in Turner syndrome or other conditions is known. The 
molecular mechanism of SHOX influence on bone development is unknown.16
Typical Phenotype of Idiopathic Scoliosis
Females with idiopathic scoliosis have tall stature.17-23  The majority of females with 
thoracic scoliosis also have a thoracic hypokyphosis, indicating possible relative 
overgrowth of the thoracic vertebral bodies, compared to the posterior elements of the 
thoracic spine.24-28  Over-stimulation of the vertebral growth plates before the onset of 
adolescence could explain these findings.29 Delayed puberty with delayed skeletal 
maturation have been implicated as risk factors for the progression of idiopathic 
scoliosis.30-32  It is now generally accepted that skeletal growth is a significant 
contributing factor to the development and natural history of idiopathic scoliosis.33,34
Comparison of Scoliosis of the Idiopathic Type and Turner Syndrome
The scoliosis in Turner syndrome is clinically and radiologically so similar to 
idiopathic scoliosis, that questions regarding a similar etiology have been raised.9-12
Turner syndrome scoliosis is usually not severe enough to require surgery, limiting 
the opportunity to acquire cartilage from the vertebral body growth plates.35-37 
However, routine surgery for idiopathic and congenital scoliosis provides that 
opportunity for the acquisition of vertebral body growth plates for analysis of SHOX 
gene expression. 
Study Aim and Design
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Normative data of SHOX gene expression in the vertebral body growth plates of a 
control female adolescent population is lacking. This study aimed to determine 
whether SHOX is expressed in vertebral body growth plates and to compare SHOX 
expression in idiopathic scoliosis versus congenital scoliosis, which demonstrate 
dissimilar phenotypes.38-40 Relative quantitative real-time PCR (qRT-PCR) 
characterized gene expression profiles for SHOX in tissue samples obtained surgically 
from vertebral body growth plate cartilage of idiopathic and congenital scoliotic 
patients as well as skeletal muscle from healthy controls (a tissue known to be 
abundant in SHOX).41 qRT-PCR’s specificity and sensitivity make this technology 
the current benchmark for high-quality, reproducible detection and comparison of 
gene expression.42
Materials and Methods
Patients and Tissues
Samples were collected from three females with idiopathic scoliosis and two 
males/one female with congenital scoliosis, as well as skeletal muscle as a positive 
SHOX control. Paravertebral skeletal muscle was collected from four healthy control 
patients. Patient demographics including diagnosis, age at the time of surgery and 
gender are listed in Table 1. Radiographs of the congenital and idiopathic scoliotic 
deformities from which the tissues were obtained are illustrated in Figures 1,2.
Tissue Harvesting
Fresh vertebral body growth plates from three patients with idiopathic scoliosis and 
three with congenital scoliosis were harvested at the time of scoliosis surgery. The 
vertebral body growth plate was sheared from the underlying vertebral body by sharp 
dissection (convex side) and curette (concave side of the curve), which revealed a thin 
layer of growth plate between the intervertebral disc and the end-plate of the vertebral 
body. Part of each specimen was immediately placed in Histochoice™ solution 
(Amresco) for a period of 72 hours to preserve cartilage whilst the other part (0.5-
1.5g) was immediately frozen in sterile vials on dry ice for RNA extraction. The 
tissue in Histochoice™ solution was subsequently stored in 70% ethanol. 
Fresh skeletal muscle was harvested from the paraspinal area of four healthy patients 
undergoing a variety of spine surgery procedures and sterile vials were also 
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immediately deposited on dry ice. Institutional Ethics permission was granted to store 
the specimens in a freezer at –800 C at the laboratory of the authors’ Institution.
Tissue Dissection
All tissues were handled under surgically sterile conditions and dissected on fresh 
histology glass slides under a NIKON YS-100 dissecting microscope. Single-use 
disposable surgical blades were used for each tissue dissection. Care was taken during 
handling to avoid specimen contamination and thawing.  
Histology
Histological examination of Haematoxylin & Eosin and Masson Trichrome stained 
paraffin-embedded sections 4-5µm thick demonstrated columns of chondrocytes 
adjacent to trabecular bone, characteristic of growth plate (Figures 3,4). An 
independent pathologist issued histology reports. Magnification images were recorded 
on analogue film and scanned, for clarity of reproduction (Figures 3,4).    Histological 
examination of the skeletal muscle demonstrated macroscopically homogeneous 
muscle.
PCR Primer Design
The nucleotide sequences for SHOX were obtained using the gene search function at 
the National Centre for Biotechnology Information (NCBI) database. Isoform variants 
were assessed for functional relevance. Candidate regions for the transcripts of 
interest were assessed for priming, taking into account RNA thermodynamics using 
Mfold.43 Primers were designed using the target specific alignment program Amplify 
(version 1.2).44 In Silico prediction of primer dynamics was assessed using both that 
program and the UCSC In Silico PCR tool.45 The non-redundant basic alignment tool, 
BLAST was used to ensure priming specificity.46 Primers for SHOX were: 5’ – GTT 
TGG TTC CAG AAC CGG AG – 3’, reverse 5’ – CTG TTG GAA AGG CAT CCG 
TA – 3’.  Primers were obtained from GeneWorks Australia.
RNA Extraction
All equipment and work areas were initially treated with RNase Zap™ (Sigma). 
Tissues removed from the liquid nitrogen were immersed in 5-10mL Trizol™ 
homogenization reagent (Invitrogen) followed by short, high-speed homogenization 
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with a CAT tissue homogenizer (M Zipperer, Germany). Further tissue disintegration 
was performed using 23-gauge needles (Terumo). The homogenate was incubated for 
5 minutes at 30°C to allow the complete dissociation of nucleoprotein complexes. 
Chloroform was then added (1.0-2.0mL) prior to vigorous agitation for 15 seconds, 
followed by another incubation period for 3 minutes at 30°C. Samples were 
transferred to 1.5mL tubes (Eppendorf) and centrifuged at 10,000rpm for 15 minutes 
at 4°C. Following centrifugation, the aqueous phase was transferred to a new sterile 
tube and RNA was precipitated with isopropanol (2.5-5mL). Samples were then 
incubated for 10 minutes at 30°C and subsequently centrifuged at 10,000rpm for 10 
minutes at 4°C. The supernatant was then removed and the RNA pellet washed with 
75% Ethanol (Analar) and then air-dried briefly. RNA purification was performed 
with an RNeasy™ Mini Kit (Qiagen). RNA was finally dissolved in UltraPure™ 
DNase/RNase-Free Distilled Water (Invitrogen).
RNA Integrity
RNA integrity was assessed using a Bio-Spec Mini™ spectrophotometer (Shimadzu), 
NanoDrop® ND-1000 spectrophotometer (NanoDrop Technologies) and standard 
denaturing gel electrophoresis. Spectrophotometric readings were obtained at neutral 
pH for absorbance at 260nm and 260:280nm with background correction of 320nm to 
allow for calculation of sample concentrations. Similarly, the ND-1000 
spectrophotometer was used to calculate RNA concentration using 1uL of total 
sample. Results from the two spectrophotometers were compared. Standard 
formaldehyde agarose gel electrophoresis (FAG) was carried out with 1.2% gel to 
visualize the integrity of the total RNA obtained from extraction. Standard, molecular 
biology grade agarose (Promega), 10X FA gel buffer (3-N-morpholino-
propanesulfonic acid, sodium acetate, ethylenediaminetetraacetic acid, sodium 
hydroxide, 37% (12.3M) formaldehyde), 1X FA running buffer (1X FA gel buffer, 
2.5M formaldehyde), 5X RNA loading buffer (Bromophenol blue, 
ethylenediaminetetraacetic acid, formaldehyde, glycerol, formamide, 10X FA gel 
buffer), and UltraPure™ DNase/RNase-Free Distilled Water (Invitrogen) were used. 
RNA samples were incubated for 5 minutes at 70°C prior to loading for 
electrophoresis.
cDNA Synthesis
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Each RNA sample was vortexed briefly to ensure homogenization and then heated to 
55°C for 5 minutes. RNA was subjected to DNase treatment using DNaseI buffer, 
0.1M DTT, and DNase I (2U/µL). DNase was heat inactivated at 65°C for 10 minutes. 
First strand synthesis of cDNA was achieved with SuperScript™ III (200U/µL) 
(Invitrogen). RNA (1-5µg) was converted using 5U/µL SuperScript™ III reverse 
transcriptase, reverse transcriptase buffer (50mM Tris-HCl pH 8.3, 75mM KCl, 3mM 
MgCl2), 10mM dNTP mix, 10µM DTT, and 50ng/µL random hexamers. The mixture 
was first heated to 65°C for 5 minutes then incubated on ice for 1 minute. 
RNaseOUT™ (40U/µL) (Invitrogen) was added to each reaction. Thermal conditions 
for synthesis were 25°C for 10 minutes, then 50°C for 50 minutes, then 85°C for 5 
minutes, followed by chilling on ice. RNase H (Invitrogen) was added to each cDNA 
sample. Three reactions were completed for quality assurance during cDNA synthesis. 
One reaction contained no reverse transcriptase, another contained no RNA, while the 
third contained genomic DNA. Products were resolved by standard agarose gel 
electrophoresis on 2% molecular biology grade agarose (Progen Biosciences) to 
verify purity and integrity. Generated cDNA samples were stored at -20°C.
qRT-PCR Optimization
Gene specific optimization on both human genomic DNA and human total RNA 
derived cDNA was performed. Optimal MgCl2 concentrations and annealing 
temperatures were determined for the PCR primers. PCR primers were designed to be 
intron-spanning as an internal control facilitating the detection of genomic 
contaminants. An appropriate normalization gene was selected based on tissue 
specific expression profiles (18S). Conditions for the target genes and the reference 
gene were determined in unison to ensure uniformity. Cycling and melt curves were 
resolved using the Corbett Rotogene 6000 real-time cycler followed by standard gel 
electrophoresis to ensure only specific, expected products were produced during PCR. 
Real-Time PCR
A Corbett Rotorgene 6000 platform performed relative quantitative real-time PCR. 
Each 25µL reaction contained 1X iQ™ SYBR® Green Supermix (Bio-Rad), 250nM 
forward and reverse primers, UltraPure™ DNase/RNase-Free Distilled Water 
(Invitrogen), 15nM Fluorosceine calibration dye, and 2µL patient cDNA. Cycling 
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conditions were: Cycle 1 (95°C for 3 minutes) X1, Cycle 2 (95°C for 30 seconds, 
57°C for 30 seconds, 72°C for 30 seconds) X45, Cycle 3 (72°C for 4 minutes) X1, 
followed by melt curve resolution ramping 50°C to 99°C increasing 1°C every 5 
seconds. Each reaction was executed in triplicate for the gene of interest, the reference 
gene and the no template control). A representative selection of amplified samples 
was resolved by standard agarose gel electrophoresis on 2% gels to check for 
specificity. Measuring gene specific PCR products provides an accurate means of 
determining mRNA relative abundance.42 Cycling data was examined and a cycle-
threshold (Ct) value was derived from the linear phase of each PCR from identical 
thresholds.
Statistical Analysis
Corbett Rotorgene 6000 software version 1.7 was used to generate and collate PCR 
data. Ct data was then exported to Microsoft Excel spreadsheets for further analysis. 
Ct methodology analyzed relative expression differences between idiopathic and 
congenital samples using 18S as the internal reference gene. Descriptive statistics 
were analyzed (including mean, SD, CV) taking into account triplicate 
reproducibility. Each patient sample’s corresponding 18S Ct value was then 
subtracted and samples grouped. Grouped samples were then compared to each other 
to determine differences. Relative differences were calculated by applying the 2-
mean(CT)
 method according to previously published methods.47  An independent 
samples T-test was then performed to determine the mean difference between 
congenital and idiopathic scoliosis at =0.05 (Table 2).
Results
RNA Integrity
Following RNA extraction, spectrophotometric yield and purity ratio were determined 
for total RNA for congenital and idiopathic scoliosis vertebral body growth plates 
(Table 3). Formaldehyde agarose gel electrophoretic patterns (FAG) were 
photographed to visually demonstrate total RNA from the vertebral body growth plate 
cartilage and the skeletal muscle. Results for the Bio-Spec Mini™ spectrophotometer 
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(Shimadzu) were comparable with the data from the NanoDrop® ND-1000 
spectrophotometer (NanoDrop Technologies).
Real Time PCR Optimisation and cDNA Quality Assurance
Cycling and melt curves were resolved for muscle (Figure 5). Agarose gel 
electrophoretic patterns were photographed to visually demonstrate SHOX 
amplification in skeletal muscle (Figure 6).  Cycling and melt curves were resolved 
for congenital and idiopathic scoliosis and analysed for the Ct values (Figures 7,8).  
Products of SHOX amplification from idiopathic and congenital scoliosis vertebral 
body growth plates were also resolved by standard agarose gel electrophoresis (Figure 
9).
Gene Expression Analysis
Relative gene expression differences were calculated using 18S as a reference gene 
and by subtracting the Ct valu  of 18S from congenital and idiopathic scoliosis, 
before comparing them to each other. Although only three samples of vertebral 
growth plate for idiopathic and congenital scoliosis were analysed, there was minimal 
variation in real corrected Ct values for each type of analysed scoliosis sample (Table 
4). Average Ct values for idiopathic and congenital scoliosis were calculated and 
compared. An 11-fold increase in SHOX expression was demonstrated in idiopathic 
compared to congenital scoliosis (Table 4). This result was statistically significant
(p=0.027).  
Comparison of Idiopathic and Congenital Scoliosis Groups
The mean age of patients in each group was calculated from age data in Table 1 at 12 
years. The patients with idiopathic scoliosis were all female and two of the three 
patients with congenital scoliosis were male.
Discussion
SHOX Gene Location and Implications for Phenotypic Variability
SHOX gene is located on the pseudo-autosomal region (PAR) of the short arm of the 
X and Y chromosomes.48 In females, one X chromosome is randomly selected for 
inactivation and appears as a Barr Body in the cell. The reason for this inactivation 
remains controversial. Genes on the PAR of the short arm of the X chromosome are 
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believed to escape X inactivation.49 Active copies of SHOX are present on both X 
chromosomes and are required for normal phenotypic expression.2 If terminal 
deletions/additions of the short arm of either the X or Y chromosome occur during 
meiosis (involving the locus for SHOX and adjacent genes), haploinsufficiency 
(reduced expression) or overdosage (increased expression) may result, and appear to 
be associated with a change in stature and dysmorphic skeletal features. 
Significance of the Results
This was a novel gene expression study of the aetiology of scoliosis as it investigated 
a specific vertebral target tissue of a gene known to be associated with dysmorphic 
peripheral skeletal development in Turner syndrome. In this pilot study, SHOX was 
abundantly expressed in all scoliotic vertebral body growth plates. It is known that 
tissue-specific gene expression may be quantitatively altered by reactions to local 
changes, such as the development of scoliosis. Although the specimens were retrieved 
from scoliotic spines not associated with Turner syndrome, the fact that SHOX was 
expressed in vertebral body growth plates is a clue for future research regarding 
altered SHOX expression and the possible subsequent development of scoliosis. 
Future quantitated genetic expression studies may also assist in determining whether 
SHOX expression is altered by age or reaction to local changes. The exact mechanism 
of SHOX influence on growth plates is currently unknown. 
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Table 1. Patient Demographics.
Patient  Gender  Age Tissue       Clinical       Curve Type Curve Angle
Idiopathic 1 F 13 Vertebral cartilage Idiopathic scoliosis Right thoracic 52
Idiopathic 2 F 13 Vertebral cartilage Idiopathic scoliosis Right thoracic 48
Idiopathic 3 F 10 Vertebral cartilage Idiopathic scoliosis Right thoracic 55
Congenital 1 M 16 Vertebral cartilage Congenital scoliosis Right thoracic 42
Congenital 2 F 12 Vertebral cartilage Congenital scoliosis Right Thoraco-lumbar 64
Congenital 3 M 9 Vertebral cartilage Congenital scoliosis Right thoracic 40
Tissue 1 M 32 Muscle Spine fracture
Tissue 2 F 17 Muscle Spine fracture
Tissue 3 M 53 Muscle Spine infection
Tissue 4 F 17 Muscle Acute disc protrusion
Figure 1. PA Plain Radiograph Congenital Scoliosis Patient # 3.
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Figure 2. PA Plain Radiograph Idiopathic Scoliosis Patient # 3.
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Figure 3. Haematoxylin & Eosin Stain x200 from Convex Side of Vertebral 
               Body Growth Plate in Congenital Scoliosis Patient # 3.
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Figure 4. Masson Trichrome Stain x400 from Concave Side of Vertebral 
               Body Growth Plate in Idiopathic Scoliosis Patient # 3.
Table 2 Statistical Analysis (Congenital versus Idiopathic Samples) Summary
Levene’s Statistic p-value T-Statistic p-value Mean Difference SE difference
3.59 0.131 3.43 0.027 3.53 1.03
Table 3 Total RNA Yield & Integrity Summary
Sample Type Mean [RNA] Mean 260:280
Idiopathic 87.62ng/uL 1.80-1.90AU
Congenital 72.67ng/uL 1.80-2.00AU
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Figure 5. Melt Analysis Demonstrating Successful SHOX Amplification
            A = No Template Control, B = 18S and C = SHOX.
Figure 6 Agarose Gel Electrophoresis of SHOX PCR Products - Muscle.       
                        Lanes 1 – 6     = 18S     
                        Lanes 7 – 12   = SHOX  Amplicon
                        Lanes 13 – 14 = No Template Control
 1  2   3  4  5  6  7  8  9 10 11 12 13 14
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Figure 7 Real-Time Amplification of SHOX
              A = 18S, B = SHOX, C=No Template Control
Figure 8 Melt Curve Showing Distinct SHOX Product in Idiopathic Samples
                      A = No Template Control, B = 18S, C = SHOX.
A
B
C
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Figure 9. Agarose Gel Electrophoretic Patterns of SHOX Amplicons in 
Congenital and Idiopathic Scoliosis Vertebral Growth Plates.
Lanes    1 – 6  = 18S             
Lanes    7 – 9 =  SHOX in Congenital Scoliosis Vertebral Growth Plates 
Lanes 10 – 12 = SHOX in Idiopathic Scoliosis Vertebral Growth Plates
Lanes 13 – 14 = No Template Control
                                          1  2  3 4  5  6  7  8  9 10 11 12 13 14
Table 4. Statistical Analysis of SHOX Expression in Idiopathic vs Congenital 
Scoliosis. 
Vertebral body growth plates Average Ct     SD     CV
Congenital scoliosis 19.86 1.72 0.09
Idiopathic scoliosis 16.33 0.45 0.03
2-mean(CT)  Ratio of Idiopathic to Congenital Scoliosis Expression  11.52-Fold.           
SD = Standard Deviation
CV = Coefficient of Variation     
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